Fill in your details to get instant access
We respect your privacy. No spam, ever.
The 42nd Pharmacovigilance India 2026 brings together regulatory officials, pharmaceutical leaders, and drug safety experts to examine emerging trends in safety surveillance and compliance. As India’s life sciences market grows rapidly, this event focuses on modernizing systems to ensure drug safety across global healthcare channels. The agenda delivers strategic guidance for implementing technological, operational, and regulatory advancements.
Explore how artificial intelligence, machine learning, and automated literature screening are transforming signal detection and drug safety workflows. Discussions center on utilizing technology to transition toward continuous risk intelligence.
Address strategic operational frameworks that effectively balance efficiency, high quality, and strict regulatory compliance. Panels evaluate India’s expanding role as a global hub for specialized pharmacovigilance services.
Reimagine risk management plans (RMPs) and risk evaluation frameworks to make sounder benefit-risk decisions. Sessions share actionable practices for maintaining safety throughout a drug’s lifecycle.
Discover practical strategies for integrating Real-World Data (RWD) and Real-World Evidence (RWE) into safety monitoring systems. Experts demonstrate how observational data can enhance signal evaluation and patient outcomes.
Examine evolving global compliance guidelines, combination product safety, and closer collaboration between industry and regulators. Speakers discuss frameworks that support innovative safety oversight.
Focus on vendor oversight, moving from effective CAPAs to a culture of compliance. Discussions outline predictive inspection strategies to address quality risks before formal findings occur.
Fill in your details to get instant access
We respect your privacy. No spam, ever.
42nd Pharmacovigilance India 2026: Shaping the Future of Drug Safety
Welcome to Virtue Insight’s 42nd Pharmacovigilance India 2026, held on July 23, 2026, at the Radisson Hotel Hyderabad Hitec City. As India’s pharmaceutical sector expands globally, maintaining robust safety surveillance is critical. This premier event brings together industry leaders, CROs, and regulatory experts to discuss key developments transforming drug safety. Key focus areas include AI-driven signal detection, automation, real-world evidence (RWE), risk management, and regulatory compliance. Designed for interactive discussion and peer-level networking, the conference offers essential insights into modernizing pharmacovigilance practices, optimizing outsourcing strategies, and strengthening patient safety standards across the global healthcare ecosystem.






















Connect directly with senior-level decision-makers and C-suite leaders from global pharmaceutical powerhouses. Engage in discussion-driven sessions designed to build strategic, high-value industry partnerships.
Explore how intelligent automation, machine learning, and AI are reshaping drug safety workflows. Learn how human-AI collaboration transitions operations toward continuous, real-time risk intelligence.
Gain up-to-date insights on global regulatory changes, combination products, and device compliance. Discover strategies to align with international regulatory expectations and maintain continuous inspection readiness.
Evaluate modern outsourcing models that effectively balance operational efficiency with rigorous quality standards. Understand how to leverage India's expanding capabilities as a reliable global pharmacovigilance hub.
Discover practical approaches for integrating Real-World Evidence (RWE) and Real-World Data (RWD) into core safety workflows. Learn to utilize observational data to refine risk management plans and enhance patient outcomes.
GLOBAL ECOSYSTEM / COMBINATION PRODUCTS
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
Explore the definitions and global regulatory trends currently shaping the combination products ecosystem. Highlighting the universal challenges
impacting industry stakeholders, regulators, and suppliers, while sharing best practices for navigating future innovations and ecosystem shifts. Emphasize
the role India (People, Process and Technology) plays in the evolution
TRANSFORMING PV OUTSOURCING
Moderator
Panellists
10:50 – MORNING COFFEE/TEA & NETWORKING
RMP – INNOVATION, INSIGHTS, IMPACT
Moderator
Panellists
Speaker TBC
Clinevo Technologies
12:40 – Networking luncheon
GCC IN PHARMA / DIGITAL TRANSFORMATION
Moderator
Panellists
SIGNAL DETECTION
SIGNAL
Pharmacovigilance transformation extends beyond technology adoption and requires effective change management. Aligning internal and external stakeholders through shared objectives, communication and governance which minimizes resistance and supports seamless implementation of new processes and digital innovations. This session explores practical strategies for stakeholder alignment that enable compliant, patient-centric, and sustainable business transformation in PV.
15:00 – Afternoon Coffee/Tea & Networking
GROWING ROLE OF RWE / RWD
Moderator
Panellists
HARMONIZING PV REGULATIONS
Moderator
Panellists
AUDITS / INSPECTION
Speakers
17:10 – Closing remarks and end of conference
We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 42nd pharmacovigilance india 2026
You can simply email or call and book your conference delegate seats on:
TEL: + 91 44 4210 8101 (or) Email — info@virtueinsight.com
We have secured special room rates for our conference participants who wish to stay at the conference venue hotel “Radisson” during the conference dates.
Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.
It was very beneficial & effective conference. Got an opportunity to meet members from PV world & learn new areas if AI, Drug Development. Would defiantly visit again if given an opportunity.
A great platform to understand the current practices & situation all across the industry, as well as individual approach of each company toward the goal of patient safety.
I would like to appreciate the efforts & initiative of Virtue Insight in organising the 17th Pharmacovigilance 2018 dedicated conference. The conference was very much interesting & was a good platform for networking, It was well organised, very insightful & a informative conference. The whole conference was more lively & in particular the panel discussions. This should happen regularly to keep PV professional updated. I have enjoyed the whole conference very much.
Had wonderful opportunity to share current challenges with Regulatory aspects of Pharmacovigilance. Very informative conference and very much needed to educated all the stake holders considering current scenario of Pharmacovigilance within our regulatory. We had very interesting discussion on CRO role for end to end Pharmacovigilance. I enjoy the way Dr. Milind handled our Panel discussion.
Very nicely managed. Good Speakers & content. Cooperative and convenient venue. Nice management of time. Good opportunity for networking
The Venue, key speakers included from big pharma companies & CROs has been perfect for the topic of panel discussion
The session was knowledge transfer/sharing and valuable too
A commercial knowledge venture explored several areas under the topic. Very good and Professional speakers.
Block 3, 86 Coombe Road
Croydon CR0 5RA
London, UK
Plot No – 07 – 2nd Floor
Ekambaram Industrial Estate
Alapakkam, Porur Chennai,
India – 600 116
Error: Contact form not found.